ATAI: Atai Life Sciences N.V. Stock

SIC 2834 – Pharmaceutical Preparations

Valuation
Market Cap ($M) 343.67
Enterprise Value ($M) 325.79
Book Value ($M) 244.32
Book Value / Share 1.47
Price / Book 1.41
NCAV ($M) 122.63
NCAV / Share 0.74
Price / NCAV 2.80

Profitability (mra)
Return on Invested Capital (ROIC) -0.15
Return on Assets (ROA) -0.14
Return on Equity (ROE) -0.17

Liquidity (mrq)
Quick Ratio 8.54
Current Ratio 8.54

Balance Sheet (mrq) ($M)
Current Assets 171.79
Assets 293.48
Liabilities 49.16
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 0.31
Operating Income -125.47
Net Income -40.22

Cash Flow Statement (mra) ($M)
Cash From Operations -84.12
Cash from Investing -53.30
Cash from Financing -8.36

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)
Change
(%)
02-13 13G/A Apeiron Investment Group Ltd. 20.10 3.72

Top 13F Investors Shares
(1000)
Change
(%)
Value
($1000)
Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2024-03-28 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-K
2023-11-14 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q
2023-08-10 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q
2023-05-11 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2024-04-16 268,384 1,176,540 22.81
2024-04-15 327,975 1,716,337 19.11
2024-04-12 373,130 275,901 135.24
2024-04-11 149,420 209,602 71.29

(click for more detail)

Similar Companies
AQST – Aquestive Therapeutics, Inc. ARCT – Arcturus Therapeutics Holdings Inc.
ARDX – Ardelyx, Inc. ATXS – Astria Therapeutics, Inc.
AUPH – Aurinia Pharmaceuticals Inc.


Financial data and stock pages provided by
Fintel.io